Sign in

CIK 0001512762

  • Accelerated filer
  • Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273615821
Phone
+1 650-649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale Director sold 99,988 shares at $0.74 ($73,881)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Shares withheld for taxes Chief Financial Officer gave up 1,711 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Commercial Officer gave up 4,858 shares (to pay taxes)
  7. 4 Shares withheld for taxes President & CEO gave up 11,810 shares (to pay taxes)
  8. 4 Derivatives Options or other derivatives
  9. 4 Shares withheld for taxes Chief Financial Officer gave up 1,711 shares (to pay taxes)
  10. 4 Shares withheld for taxes President & CEO gave up 11,810 shares (to pay taxes)
  11. 4 Derivatives Options or other derivatives
  12. 4 Shares withheld for taxes Chief Commercial Officer gave up 2,277 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Commercial Officer gave up 2,073 shares (to pay taxes)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 20 · 399 filings